Botulinum Toxin as a Biological Weapon
JAMA 285:1059-1070, Arnon,S.S.,et al, 2001
Sudden Sensorineural Hearing Loss Associated with Herpes Simplex Virus Type 1 Infection
Neurol 56:571-572, Rabinstein,A.,et al, 2001
Guillain-Barre Syndrome Complicated with Hemolytic Anemia in Association with Antiganglioside GM3 Antibody
Am J Med 110:399-400, Aoyama,K.,et al, 2001
The Outbreak of West Nile Virus Infection in the New York City Area in 1999
NEJM 344:1807-1814,1858, Nash,D.,et al, 2001
Anticipating Mechanical Ventilation in Guillain-Barre Syndrome
Arch Neurol 58:893-898,871, Lawn,N.D.,et al, 2001
Early Electrodiagnostic Findings in Guillain-Barre Syndrome
Arch Neurol 58:913-917, Gordon,P.H. & Wilbourn,A.J., 2001
Wartenberg's Migrant Sensory Neuritis
Muscle & Nerve 24:438-443, Nicolle,M.W.,et al, 2001
Mild Guillain-Barre Syndrome
Arch Neurol 58:1098-1101, Green,D.M. &Ropper,A.H., 2001
Bilateral Abducens Nerve Paresis Associated with Anti-GQ1b IgG Antibody
Am J Ophthalmol 131:816-818, Sato, K. and Yoshikawa, H., 2001
Acute Hepatic Encephalopathy with Diffuse Cortical Lesions
Neuroradiology 43:551-554, Arnold, S.M.,et al, 2001
Neurological manifestations in Chronic Mountain Sickness: The Burning Feet-Burning Hands Syndrome
JNNP 69:447-452, Thomas,P.K.,et al, 2000
Visual Manifestations of Giant Cell Arteritis
Medicine 79:283-292, Gonzalez-Gay,M.A.,et al, 2000
A Six-Year-Old Girl with Tick paralysis
NEJM 342:90-94, Felz,M.W.,et al, 2000
The Nonmotor Problems of Parkinson's Disease
The Neurologist 6:18-27, Friedman,J.H.&Fernandez,H.H., 2000
Neurologic Complications of the Reactivation of Varicella-Zoster Virus
NEJM 342:635-645, Gilden,D.H.,et al, 2000
Nitrous Oxide Anesthesia-Associated Myelopathy
ArchNeurol 57:380-382, Marie,R.,et al, 2000
Primary Neurosarcoidosis:A Diagnostic and Therapeutic Challenge
The Neurologist 6:126-133, Nikhar,N.K.,et al, 2000
Cardiac Dysfunction in Neuromuscular Diseases
The Neurologist 6:67-82, Pourmand,R., 2000
Long-Term outcome in Patients With Guillain-Barre Syndrome Requiring Mechanical Ventilation
Neurol 54:2311-2315, Fletcher,D.D.,et al, 2000
Influenza Vaccine and the Risk of Relapse of Guillain-Barre Syndrome
Neurol 55:452-453, Wijdicks,E.F.M. et al, 2000
Poliomyelitic-Like Illness in Central European Encephalitis
Neurol 55:299-302, Schellinger,P.D. et al, 2000
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Human Immunodeficiency Virus-Associated Pure motor Lumbosacral Polyradiculopathy
Arch Neurol 57:1034-1039, Benatar,M.G. & Eastman,R.W., 2000
Guillain-Barre Syndrome: An Unusual Presentation of West Nile Virus Infection
Neurol 55:144-146, Ahmed,S. et al, 2000
Guillain-Barre Syndrome in a Patient with Non-Hodgkins Lymphoma
Ann Oncol 11:217-220, Schwenk,D.Re.,et al, 2000
Bilateral Posterior Ischemic Optic Neuropathy After Spinal Surery
Am J Ophthal 127:354-355, Alexandrakis,G.&Lam,B.L., 1999
SIADH as the First Symptom of Guillain-Barre Syndrome
Neurol 53:1365, Hofmann,O.,et al, 1999
Hypertrophy of Multiple Cranial Nerves and Spinal Roots in Chronic Inflammatory Demyelinating Neuropathy
JNNP 67:685-687, Duarte,J.,et al, 1999
Clinicopath Conf,Guillain-Barre Syndrome, Campylobacter Jejuni Enteritis,Case 39-1999
NEJM 341:1996-2003, , 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Neurology and the Skin
JNNP 66:417-430, Hurko,O.&Provost,T.T., 1999
Critical Illness Neuropathy and Myopathy
Arch Neurol 56:527-528, Gutmann,L.&Gutmann,L., 1999
Chronic Cryptogenic Sensory Polyneuropathy,Clinical and Laboratory Characteristics
Arch Neurol 56:540-547, 519, Wolfe,G.I.,et al, 1999
Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Paraneoplastic Syndromes
Arch Neurol 56:405-408, Dalmau,J.O.&Posner,J.B., 1999
Acute and Reversible Parkinsonism Due to Organophosphate Pesticide Intoxication, Five Cases
Neurol 52:1467-1471, Bhatt,M.H.,et al, 1999
Carcinoma Associated Paraneoplastic Peripheral Neuropathies in Patients with and without Anti-Onconeural Antibodies
JNNP 67:7-14,4, Antoine,J.,et al, 1999
Paraneoplastic Painful Ulnar Neuropathy
Muscle & Nerve 22:952-955, Sharief,M.K.,et al, 1999
Pain and the Guillain-Barre Syndrome in Children Under 6 Years
J Pediatr 134:773-776, Nguyen,D.K.,et al, 1999
Presenting Features and Value of Diagnostic Procedures in Leptomeningeal Metastases
Neurol 53:382-385, van Oostenbrugge,R.J.&Twijnstra,A., 1999
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Tracheostomy, In Guillain- Barre Syndrome
Muscle & Nerve 22:1058-1062, Lawn,N.D.&Wijdicks,E.F.M., 1999
Neuro-Ophthalmic Manifestations of Diabetes
Ophthalmology 106:1047-1048, Sadun,A.A., 1999
Neurologic Complications Associated with Hepatitis C Virus Infection
Neurol 53:861-864, Tembl,J.I.,et al, 1999
Neurologic Complications in Children with Enterovirus 71 Infection
NEJM 341:936-942, Huang,C-C.,et al, 1999
Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999
The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999
Fatal Guillain-Barre Syndrome
Neurol 52:635-638, Lawn,N.D.&Wijdicks,E.F.M., 1999